Showing results 1 to 1 of 1
| Issue Date | Title | Journal Title |
|---|---|---|
| 2025 | Primary Analysis of EPIK-O/ENGOT-ov61: Alpelisib Plus Olaparib Versus Chemotherapy in Platinum-Resistant or Platinum-Refractory High-Grade Serous Ovarian Cancer Without BRCA Mutation | JOURNAL OF CLINICAL ONCOLOGY |